Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

10 treatments under study, led by Activetdcs

Research Leaders

10 sponsors active, led by Riphah International University

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 6 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (6)

Trial Status

Completed3
Unknown2
Suspended1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Activetdcs1
  • Oneweek Speech Therapy Group1
  • Shamtdcs1
  • Teletherapy1
  • Traditionally Speech Therapy1

Active Sponsors

  • Riphah International University2
  • Northumberland Care Trust1
  • Newcastle-upon-Tyne Hospitals NHS Trust1
  • Irish Research Council1
  • SynthezAI Corp.1

Top Investigators

Related Conditions

  • Stuttering Adult2

Activity Timeline